News & Analysis on Clinical Trial Services & Contract Research And Development
in-PharmaTechnologist.com presents its weekly round-up of the latest new faces and changing places in the world of pharmaceuticals, including news from AstraZeneca, Cresset and Aurobindo.
The lack of competing studies, proximity to the SFDA HQ and were the key drivers for the new Beijing, China office according to PRA International.
EXCLUSIVE
GlaxoSmithKline (GSK) and AstraZeneca have been attracted by NHS efforts to work with sponsors and CROs outside the UK according to Government investment group, UK Trade and Investment.
Vitamin B3 may be used to improve the efficacy of antibiotics when treating drug-resistant ‘superbug’ infections such as MRSA, according to new research.
The CDSCO wants to expand its pool of reviewers for drug applications, clinical trials and medical devices and is seeking applications from experts.
Charles River Laboratories has acquired Accugenix in a bid to expand its endotoxin and microbial detection portfolio.
The PRACS Institute has sold its Miami, US facility to a new early-phase focused CRO, CRI Phase I Corporation.